These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3031743)

  • 1. Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats.
    Plotsky PM
    Regul Pept; 1986 Dec; 16(3-4):235-42. PubMed ID: 3031743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection.
    Plotsky PM
    Endocrinology; 1987 Sep; 121(3):924-30. PubMed ID: 3497798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation by delayed glucocorticoid feedback.
    Plotsky PM; Otto S; Sapolsky RM
    Endocrinology; 1986 Sep; 119(3):1126-30. PubMed ID: 3015567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin.
    Plotsky PM; Bruhn TO; Vale W
    Endocrinology; 1984 Oct; 115(4):1639-41. PubMed ID: 6332731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between immunoreactive corticotropin-releasing factor concentration profiles in hypophysial-portal and peripheral plasma.
    Plotsky PM; Otto S; Toyama T; Sutton S
    J Neuroendocrinol; 1990 Feb; 2(1):65-9. PubMed ID: 19210399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.
    Gibbs DM; Vale W
    Endocrinology; 1982 Oct; 111(4):1418-20. PubMed ID: 6288364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.
    Petraglia F; Vale W; Rivier C
    Endocrinology; 1986 Dec; 119(6):2445-50. PubMed ID: 2877862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the role of angiotensin II in mediation of adrenocorticotropin secretion.
    Plotsky PM; Sutton SW; Bruhn TO; Ferguson AV
    Endocrinology; 1988 Feb; 122(2):538-45. PubMed ID: 2828001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
    Petraglia F; Sutton S; Vale W; Plotsky P
    Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides.
    Buckingham JC
    Neuroendocrinology; 1982; 35(2):111-6. PubMed ID: 6290921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation.
    Plotsky PM; Otto S; Sutton S
    Life Sci; 1987 Sep; 41(10):1311-7. PubMed ID: 3498106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Yajima F; Suda T; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Life Sci; 1986 Jul; 39(2):181-6. PubMed ID: 2873496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by corticotropin-releasing factor.
    Plotsky PM; Bruhn TO; Otto S
    Endocrinology; 1985 Apr; 116(4):1669-71. PubMed ID: 3871693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia.
    Plotsky PM; Bruhn TO; Vale W
    Endocrinology; 1985 Jul; 117(1):323-9. PubMed ID: 2988921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.
    Guillaume V; Conte-Devolx B; Szafarczyk A; Malaval F; Pares-Herbute N; Grino M; Alonso G; Assenmacher I; Oliver C
    Neuroendocrinology; 1987 Aug; 46(2):143-6. PubMed ID: 2819759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concentration of arginine vasopressin in pituitary stalk plasma of the rat after adrenalectomy or morphine.
    Koenig JI; Meltzer HY; Devane GD; Gudelsky GA
    Endocrinology; 1986 Jun; 118(6):2534-9. PubMed ID: 2938937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat.
    Koenig JI; Meltzer HY; Gudelsky GA
    Neuroendocrinology; 1986; 43(5):611-7. PubMed ID: 2944026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular injection of platelet-activating factor induces secretion of adrenocorticotropin, beta-endorphin and corticosterone in conscious rats: a possible link between the immune and nervous systems.
    Rougeot C; Junier MP; Minary P; Weidenfeld J; Braquet P; Dray F
    Neuroendocrinology; 1990 Mar; 51(3):267-75. PubMed ID: 2157993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.